These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8781317)

  • 1. Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa.
    Gregorio GV; Jones H; Choudhuri K; Vegnente A; Bortolotti F; Mieli-Vergani G; Vergani D
    Hepatology; 1996 Sep; 24(3):520-3. PubMed ID: 8781317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha.
    Kansu A; Kuloğlu Z; Demirçeken F; Girgin N
    Turk J Gastroenterol; 2004 Dec; 15(4):213-8. PubMed ID: 16249973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection.
    Gregorio GV; Pensati P; Iorio R; Vegnente A; Mieli-Vergani G; Vergani D
    Clin Exp Immunol; 1998 Jun; 112(3):471-6. PubMed ID: 9649217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies in children with chronic hepatitis B undergoing interferon therapy.
    Kacprzak-Bergman I; Zaleska I; Gruszka J; Kuchar E
    Med Sci Monit; 2002 Dec; 8(12):CR821-4. PubMed ID: 12503042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection.
    Rocco A; Gargano S; Provenzano A; Nardone M; De Sanctis GM; Altavilla N; Chircu LV; Grimaldi F
    Neuro Endocrinol Lett; 2001; 22(1):39-44. PubMed ID: 11335878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
    Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
    Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of organ- and non-organ-specific autoantibodies on the response to anti-viral treatment of patients with chronic hepatitis C.
    Gatselis NK; Georgiadou SP; Koukoulis GK; Tassopoulos N; Zachou K; Liaskos C; Hatzakis A; Dalekos GN
    Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1563-73. PubMed ID: 17094775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies during alpha-interferon therapy for chronic hepatitis B.
    Fattovich G; Betterle C; Brollo L; Pedini B; Giustina G; Realdi G; Alberti A; Ruol A
    J Med Virol; 1991 Jun; 34(2):132-5. PubMed ID: 1890413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection.
    Marinos G; Naoumov NV; Williams R
    Hepatology; 1996 Nov; 24(5):991-5. PubMed ID: 8903365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
    Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
    Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
    Ozgenç F; Arikan C; Sertoz RY; Nart D; Aydogdu S; Yagci RV
    Antivir Ther; 2004 Oct; 9(5):729-32. PubMed ID: 15535410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
    Yuen MF; Hui CK; Cheng CC; Wu CH; Lai YP; Lai CL
    Hepatology; 2001 Jul; 34(1):139-45. PubMed ID: 11431745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome in children with chronic hepatitis B: a 24-year observation period.
    Iorio R; Giannattasio A; Cirillo F; D' Alessandro L; Vegnente A
    Clin Infect Dis; 2007 Oct; 45(8):943-9. PubMed ID: 17879906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence and significance of non-specific anti-organelle antibodies of the liver in chronic viral hepatitis C].
    Borotto E; Lunel F; Valla D; Abuaf N; Perrin M; Bousquet JC; Opolon P; Homberg JC
    Gastroenterol Clin Biol; 1994; 18(10):813-8. PubMed ID: 7875387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-alpha treatment of children with chronic hepatitis D virus infection: the Greek experience.
    Dalekos GN; Galanakis E; Zervou E; Tzoufi M; Lapatsanis PD; Tsianos EV
    Hepatogastroenterology; 2000; 47(34):1072-6. PubMed ID: 11020882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of different combination therapies for children with HBeAg positive chronic hepatitis B].
    Zhong XH; Deng X; Chen XC; Zhou BP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):62-3. PubMed ID: 17429539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon and steroid treatment in patients with chronic hepatitis C and antinuclear or anti-liver-kidney microsomal antibodies.
    Provenzano G; Almasio P; Fabiano C; Magrin S; Pinzello G; Vaccaro A; Craxì A
    Ital J Gastroenterol; 1996 Sep; 28(7):377-80. PubMed ID: 8937938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.